[HTML][HTML] Barriers to participation in clinical trials: a physician survey

A Mahmud, O Zalay, A Springer, K Arts… - Current …, 2018 - pmc.ncbi.nlm.nih.gov
Background Clinical trials are vital for evidence-based cancer care. Oncologist engagement
in clinical trials has an effect on patient recruitment, which in turn can affect trial success …

Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation

JM Unger, R Vaidya, DL Hershman… - JNCI: Journal of the …, 2019 - academic.oup.com
Background Barriers to cancer clinical trial participation have been the subject of frequent
study, but the rate of trial participation has not changed substantially over time. Studies often …

A population-based assessment of specialty physician involvement in cancer clinical trials

CN Klabunde, NL Keating, AL Potosky… - Journal of the …, 2011 - academic.oup.com
Background Clinical trials are critical for evaluating new cancer therapies, but few adult
patients participate in them. Physicians have an important role in facilitating patient …

Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients

GC Hillyer, M Beauchemin, DL Hershman… - Clinical …, 2020 - journals.sagepub.com
Background/Aims Essential to bringing innovative cancer treatments to patients is voluntary
participation in clinical trials but approximately 8% of American cancer patients are enrolled …

[HTML][HTML] Access to clinical trials among oncology patients: results of a cross sectional survey

M Carey, AW Boyes, R Smits, J Bryant, A Waller, I Olver - BMC cancer, 2017 - Springer
Background Clinical trials are necessary for the advancement of cancer treatment and care,
however low rates of participation in such trials limit the generalisability of findings. The …

Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates

E Grunfeld, L Zitzelsberger, M Coristine, F Aspelund - Cancer, 2002 - Wiley Online Library
BACKGROUND The literature continues to report low rates of accrual to cancer clinical trials.
Previous studies have examined principally physician‐related or patient‐related barriers …

“When offered to participate”: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials

JM Unger, DL Hershman, C Till… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Patient participation in clinical trials is vital for knowledge advancement and
outcomes improvement. Few adult cancer patients participate in trials. Although patient …

Clinical trial discussion, referral, and recruitment: physician, patient, and system factors

CP Kaplan, AM Nápoles, D Dohan… - Cancer Causes & …, 2013 - Springer
Purpose Patient participation in cancer clinical trials is imperative to the advancement of
medical science. Physicians play an important role in recruitment by discussing clinical trials …

Assessment of perceived cost to the patient and other barriers to clinical trial participation

DJ Weckstein, CA Thomas, IF Emery… - Journal of Oncology …, 2011 - ascopubs.org
Purpose: Less than 5% of patients with cancer participate in trials. Few studies have
specifically addressed the role of cost to the patient as an influence on trial participation. Our …

[HTML][HTML] Role of clinical trial participation in cancer research: barriers, evidence, and strategies

JM Unger, E Cook, E Tai, A Bleyer - American Society of Clinical …, 2016 - ncbi.nlm.nih.gov
Fewer than 1 in 20 adult cancer patients enroll in cancer clinical trials. But although barriers
to trial participation have been the subject of frequent study, the rate of trial participation has …